scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Nicola Volpi | Q39485241 |
P2093 | author name string | Nicola Volpi | |
P2860 | cites work | Osteoarthritis and its management - Epidemiology, nutritional aspects and environmental factors | Q91434486 |
Keratan Sulphate, a complex Glycosaminoglycan with Unique Functional Capability | Q47860795 | ||
Osteoarthritis year in review 2017: clinical. | Q49922324 | ||
Senescent cells and osteoarthritis: a painful connection. | Q52613753 | ||
Pharmaceutical grade chondroitin sulfate: Structural analysis and identification of contaminants in different commercial preparations | Q57158040 | ||
Knee osteoarthritis: pathophysiology and current treatment modalities | Q57483114 | ||
Osteoarthritis year in review 2018: genetics and epigenetics | Q58389751 | ||
Structural characterization of chondroitin sulfate from sturgeon bone | Q62716270 | ||
Demonstration of immunogenic keratan sulphate in commercial chondroitin 6-sulphate from shark cartilage. Implications for ELISA assays | Q71730626 | ||
Hyaluronic acid and chondroitin sulfate unsaturated disaccharides analysis by high-performance liquid chromatography and fluorimetric detection with dansylhydrazine | Q73301523 | ||
Disaccharide analysis and molecular mass determination to microgram level of single sulfated glycosaminoglycan species in mixtures following agarose-gel electrophoresis | Q78198082 | ||
Identification of the origin of chondroitin sulfate in "health foods" | Q79701664 | ||
Residual keratan sulfate in chondroitin sulfate formulations for oral administration | Q84641715 | ||
A brief practical review of size exclusion chromatography: Rules of thumb, limitations, and troubleshooting | Q88734773 | ||
Efficacy of commonly prescribed analgesics in the management of osteoarthritis: a systematic review and meta-analysis | Q91014563 | ||
Structural analysis of glucans | Q26865054 | ||
Electrophoretic separation of alginic sodium diester and sodium hexametaphosphate in chondroitin sulfate that interfere with the cetylpyridinium chloride titration assay | Q30867717 | ||
Immunological activity of chondroitin sulfate | Q33994668 | ||
Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate | Q34271235 | ||
Biochemical basis of the pharmacologic action of chondroitin sulfates on the osteoarticular system | Q34335964 | ||
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events | Q34774203 | ||
Electrophoretic approaches to the analysis of complex polysaccharides. | Q36418606 | ||
Therapeutic applications of glycosaminoglycans | Q36512850 | ||
Role of the sulfation pattern of chondroitin sulfate in its biological activities and in the binding of growth factors | Q36713851 | ||
Analytical aspects of pharmaceutical grade chondroitin sulfates. | Q36881374 | ||
Capillary electrophoresis of complex natural polysaccharides | Q37218824 | ||
The potential of chondroitin sulfate as a therapeutic agent | Q37228620 | ||
Immunomodulatory and anti-inflammatory effects of chondroitin sulphate | Q37310621 | ||
Recent progress and applications in glycosaminoglycan and heparin research | Q37455553 | ||
Quality of different chondroitin sulfate preparations in relation to their therapeutic activity | Q37611121 | ||
Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes | Q37671601 | ||
Pharmacologic therapy for osteoarthritis—the era of disease modification | Q37809746 | ||
Anti-inflammatory activity of chondroitin sulphate: new functions from an old natural macromolecule | Q37951364 | ||
Glycosaminoglycan polysaccharide biosynthesis and production: today and tomorrow | Q37990761 | ||
An overview of the diagnostic tools | Q38127520 | ||
Condrosulf®: structural characterization, pharmacological activities and mechanism of action | Q38253219 | ||
Discrepancies in composition and biological effects of different formulations of chondroitin sulfate. | Q38371965 | ||
Molecular interactions between chondroitin-dermatan sulfate and growth factors/receptors/matrix proteins | Q38545290 | ||
Chondroitin sulphate: a focus on osteoarthritis | Q38838064 | ||
An update on the up and coming therapies to treat osteoarthritis, a multifaceted disease. | Q38871811 | ||
New variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy | Q41717729 | ||
About oral absorption and human pharmacokinetics of chondroitin sulfate | Q43051046 | ||
Determination of molecular mass values of chondroitin sulfates by fluorophore-assisted carbohydrate electrophoresis (FACE). | Q43237336 | ||
High-performance liquid chromatography and on-line mass spectrometry detection for the analysis of chondroitin sulfates/hyaluronan disaccharides derivatized with 2-aminoacridone | Q43273475 | ||
Detection of keratan sulfate by immunological methods in commercial chondroitin sulfate preparations | Q43700679 | ||
Selective removal of keratan sulfate in chondroitin sulfate samples by sequential precipitation with ethanol | Q44038764 | ||
Oral bioavailability of chondroitin sulfate (Condrosulf) and its constituents in healthy male volunteers | Q44163866 | ||
Oral absorption and bioavailability of ichthyic origin chondroitin sulfate in healthy male volunteers | Q44474736 | ||
Capillary electrophoresis for the quality control of chondroitin sulfates in raw materials and formulations | Q46869831 | ||
Recent advances in spectroelectrochemistry | Q47705710 | ||
P275 | copyright license | Creative Commons Attribution | Q6905323 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | osteoarthritis | Q62736 |
chondroitin sulfate | Q408014 | ||
dietary supplement | Q645858 | ||
P304 | page(s) | 1447 | |
P577 | publication date | 2019-04-12 | |
P1433 | published in | Molecules | Q151332 |
P1476 | title | Chondroitin Sulfate Safety and Quality | |
P478 | volume | 24 |
Search more.